Tonix Pharmaceuticals Holding (TNXP) Inventory Average (2023 - 2026)

Tonix Pharmaceuticals Holding has reported Inventory Average for 4 years, with the latest figure at $4.2 million in Q2 2026.

• On a quarterly basis, Inventory Average fell 41.06% year-over-year to $4.2 million in Q2 2026; TTM through Jun 2026 was $4.2 million, a 41.06% decrease from a year earlier, with the FY2025 full-year figure at $7.2 million, down 34.59% from the prior year.
• Inventory Average was $4.2 million for Q2 2026 at Tonix Pharmaceuticals Holding, down from $4.8 million in the prior quarter.
• The five-year high for Inventory Average was $13.5 million in Q3 2023, with the low at $4.2 million in Q2 2026.
• Average Inventory Average over 4 years is $8.7 million, with a median of $8.2 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Inventory Average decreased 28.14% in 2025, then plunged 41.62% in 2026.
• Over 4 years, Inventory Average stood at $13.5 million in 2023, then plunged by 39.43% to $8.2 million in 2024, then decreased by 28.14% to $5.9 million in 2025, then fell by 29.12% to $4.2 million in 2026.
• The last three Inventory Average figures came in at $4.2 million (Q2 2026), $4.8 million (Q1 2026), and $5.9 million (Q4 2025), per Business Quant data.